| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| MIR186 |
|
microRNA 186
|
|
|
0.551 |
0.808 |
| PWAR4 |
|
Prader Willi/Angelman region RNA 4
|
|
|
0.573 |
0.769 |
| MIR30D |
|
microRNA 30d
|
|
|
0.563 |
0.654 |
| MIR30E |
|
microRNA 30e
|
|
|
0.576 |
0.769 |
| XRCC6P5 |
|
X-ray repair cross complementing 6 pseudogene 5
|
|
|
0.579 |
0.769 |
| SNHG1 |
|
small nucleolar RNA host gene 1
|
|
|
0.576 |
0.692 |
| CCAT1 |
|
colon cancer associated transcript 1
|
|
|
0.585 |
0.500 |
| PDR |
|
pigment disorder, reticulate
|
|
|
0.592 |
0.692 |
| AFAP1-AS1 |
|
AFAP1 antisense RNA 1
|
|
|
0.573 |
0.538 |
| SOX2-OT |
|
SOX2 overlapping transcript
|
|
|
0.597 |
0.615 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| HULC |
|
hepatocellular carcinoma up-regulated long non-coding RNA
|
|
|
0.606 |
0.538 |
| MIR485 |
|
microRNA 485
|
|
|
0.593 |
0.731 |
| MIR490 |
|
microRNA 490
|
|
|
0.588 |
0.538 |
| PSC |
|
Cholangitis, primary sclerosing
|
|
|
0.603 |
0.731 |
| RAB7B |
Q96AH8
|
RAB7B, member RAS oncogene family
|
|
|
0.615 |
0.731 |
| TP73-AS1 |
|
TP73 antisense RNA 1
|
|
|
0.599 |
0.577 |
| DANCR |
P0C864
|
differentiation antagonizing non-protein coding RNA
|
|
|
0.601 |
0.615 |
| CCAT2 |
|
colon cancer associated transcript 2
|
|
|
0.621 |
0.615 |
| SPRY4-IT1 |
|
SPRY4 intronic transcript 1
|
|
|
0.619 |
0.462 |
| LPAL2 |
Q16609
|
lipoprotein(a) like 2, pseudogene
|
Enzyme
|
|
0.626 |
0.731 |
| PANDAR |
|
promoter of CDKN1A antisense DNA damage activated RNA
|
|
|
0.623 |
0.577 |
| CDR1-AS |
|
CDR1 antisense RNA
|
|
|
0.623 |
0.654 |
| MIR622 |
|
microRNA 622
|
|
|
0.638 |
0.500 |